News

SWOG researchers report results in rare gynecologic cancers from S1609 DART immunotherapy trial

SWOG S1512 trial sees high response rate to pembrolizumab in patients with unresectable desmoplastic melanoma

SWOG S2302 Pragmatica-Lung study opens to enrollment, a model for easier, more representative clinical trials

SWOG's board of governors has voted to amend the constitution to include an option for SWOG to be led by group co-chairs

COMING SOON: SWOG Membership Profiles Will Answer The Question "Who Are We?"

Back to San Francisco